Month: June 2026

The University Hospital of Neurology in Ulm is currently conducting a placebo-controlled study on the efficacy of a high-calorie, high-fat dietary supplement (LIPCAL-ALS II). Twenty-six centers from the German ALS Network (MND-Net) are participating in the study. This investigator-initiated trial…

The successful conclusion of the agreement to conduct an innovative clinical trial marks an important milestone. The trial will evaluate a potential drug for people with C9orf72-ALS—the most common genetic form of the disease. The study’s methodological approach is particularly…